Nuclear protein in testis midline carcinoma misdiagnosed as adamantinoma

J Clin Oncol. 2014 May 20;32(15):e57-60. doi: 10.1200/JCO.2012.48.5300. Epub 2014 Jan 27.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adamantinoma / chemistry
  • Adamantinoma / diagnosis*
  • Adamantinoma / genetics
  • Adamantinoma / pathology
  • Adolescent
  • Biomarkers, Tumor / analysis*
  • Biomarkers, Tumor / genetics
  • Biopsy
  • Bone Neoplasms / chemistry
  • Bone Neoplasms / diagnosis*
  • Bone Neoplasms / genetics
  • Bone Neoplasms / secondary
  • Bone Neoplasms / therapy
  • Carcinoma / chemistry
  • Carcinoma / diagnosis*
  • Carcinoma / genetics
  • Carcinoma / secondary
  • Carcinoma / therapy
  • Diagnostic Errors*
  • Disease Progression
  • Fatal Outcome
  • Female
  • Femoral Neoplasms / chemistry
  • Femoral Neoplasms / diagnosis*
  • Femoral Neoplasms / genetics
  • Femoral Neoplasms / secondary
  • Femoral Neoplasms / therapy
  • Humans
  • Immunohistochemistry
  • Lung Neoplasms / chemistry
  • Lung Neoplasms / diagnosis*
  • Lung Neoplasms / genetics
  • Lung Neoplasms / pathology
  • Lung Neoplasms / therapy
  • Lymphatic Metastasis
  • Neoplasm Proteins
  • Nuclear Proteins / analysis*
  • Nuclear Proteins / genetics
  • Oncogene Proteins / analysis*
  • Oncogene Proteins / genetics
  • Predictive Value of Tests
  • Tibia / chemistry
  • Tibia / pathology*
  • Tomography, X-Ray Computed
  • Treatment Failure
  • Whole Body Imaging

Substances

  • Biomarkers, Tumor
  • NUTM1 protein, human
  • Neoplasm Proteins
  • Nuclear Proteins
  • Oncogene Proteins